drugset / Trial / NCT02805855

Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis

NCT02805855

Phase 1 Completed 15 enrolled Jacob L. Sellon, M.D.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study seeks to determine the safety and feasibility of using adipose-derived mesenchymal stromal cells to treat symptoms of mild to severe knee osteoarthritis.

Timeline

Start
2016-10-26
Primary completion
2023-09-28
Completion
2023-09-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Adipose-Derived Mesenchymal Stromal Cells Cell therapy 5e+07 cells
Subject Autologous Adipose-Derived Mesenchymal Stromal Cells Cell therapy 1e+08 cells

Indications